drugset / Trial / NCT05827484

The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries

NCT05827484

Phase 4 Completed 20 enrolled Mostafa Hassanein, Msc
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this comparative study is to determine whether or not LOSARTAN with its anti-fibrotic action has an added effect when administrated with platelet rich plasma injection on skeletal muscle healing and on decreasing the fibrous scar after muscle injuries in comparison with the sole administration of platelet rich plasma.

Timeline

Start
2016-10-10
Primary completion
2017-09-05
Completion
2017-12-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Autologous platelets rich plasma Unknown 3 ml Other
Subject Losartan Other / unclassified 50 mg Oral

Indications

No indication recorded.